A wide variety of COVID-19 symptoms exist, ranging from mild to severe, and while current strains of the virus generally cause milder symptoms, those with co-morbidities are still at an exponentially greater risk of severe disease.
Study links nasal autoantibodies to COVID-19 severity prediction
- Post author:
- Post published:November 6, 2024
- Post category:uncategorized